Alnylam Pharmaceuticals, Inc.
(ALNY - NASDAQ)
311,13 USD
📋 Profilo Aziendale

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference.

|